CORDIS
EU research results

CORDIS

English EN
METAbolism analysis made easy for CELL Translational Medicine

METAbolism analysis made easy for CELL Translational Medicine

Objective

"The healthcare industry is experiencing unprecedented rates of drug failure, long development times and high costs - because current lab tests and disease models (in vitro) don’t adequately predict drug effect in the patient (in vivo).

To address this “Challenge”, three leading EU SMEs; Luxcel Biosciences Ltd, Axiogenesis AG and BMG Labtech GmbH, are partnering to bring to market, a fully integrated targeted metabolomics Test Platform, comprising physiologically relevant in vitro cell assays and easy to use test kits, configured for use with the multimode fluorescence plate reader; instrumentation, which is installed in, or else is easily accessible to every cell biology lab globally.

The innovation “Solution"" is made possible by Luxcel’s unique and patented optical nanosensor technology, and its integration to create entirely new ‘functionally-connected’ in vitro tests. The scope of the project is to finalize development of the cell-based assay platform towards market introduction, productise, pilot and demonstrate it with key opinion leaders; for modular product launch through the project and full launch early 2019.

Leveraging existing global sales channels, the three industrial partners are targeting revenues of EUR 15 million by 2023. In total, about 24-29 new jobs will be created by 2023; with 6 new jobs during the project. All three SMEs are passionate about the MetaCell-TM solution, and expect that a successful outcome will see them positioned as No. 1 in their respective fields in Europe and internationally.
"
Leaflet | Map data © OpenStreetMap contributors, Credit: EC-GISCO, © EuroGeographics for the administrative boundaries

Coordinator

LUXCEL BIOSCIENCES LTD

Address

Biotransfer Unit Suite 3-32 Biol
T12 Cork

Ireland

Activity type

Private for-profit entities (excluding Higher or Secondary Education Establishments)

EU Contribution

€ 695 481,17

Participants (5)

Sort alphabetically

Sort by EU Contribution

Expand all

BMG LABTECH GMBH

Germany

EU Contribution

€ 492 081,25

NCARDIA AG

Germany

EU Contribution

€ 556 437,50

THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD

United Kingdom

EU Contribution

€ 249 268,75

IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE

United Kingdom

EU Contribution

€ 226 187,50

AGILENT TECHNOLOGIES IRELAND LIMITED

Ireland

EU Contribution

€ 240 159,96

Project information

Grant agreement ID: 737978

Status

Closed project

  • Start date

    1 November 2016

  • End date

    30 April 2019

Funded under:

H2020-EU.3.

H2020-EU.2.

  • Overall budget:

    € 3 313 827,50

  • EU contribution

    € 2 459 616,13

Coordinated by:

LUXCEL BIOSCIENCES LTD

Ireland